Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can remote exercise sessions boost heart recovery after ablation?

NCT ID NCT07808307

Disease control Sponsor: Hande Cörüt Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether a 12-week remotely supervised exercise program can improve recovery in adults aged 50 to 75 who had catheter ablation for atrial fibrillation. Participants are randomly assigned to either the telerehabilitation group, which does aerobic, strengthening, and stretching exercises three days a week, or a control group receiving standard care and general exercise advice. Researchers measure exercise capacity, muscle strength, heart function, quality of life, and whether atrial fibrillation returns. The goal is to see if a home-based program can offer benefits similar to in-person cardiac rehab.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week remotely supervised cardiac telerehabilitation exercise program with aerobic, strengthening, and stretching exercises, three days per week.
What this could lead to
If effective, this approach could offer a convenient, home-based way to improve exercise capacity and quality of life after atrial fibrillation ablation, potentially reducing recurrence.
What could go wrong
The trial is small (28 participants) and early, so results may not apply broadly. Exercise programs can be hard to stick with, and the study does not guarantee long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 50-75 years. * Diagnosed with atrial fibrillation and treated with catheter ablation. * Have a smartphone or computer compatible with the digital equipment provided for the study. * Have access to the Internet. * Provide written informed consent to participate in the study. Exclusion Criteria * Presence of a non-cardiovascular condition (orthopedic or neurological) that limits participation in exercise. * Acute heart failure, cancer, or worsening of a comorbid condition within the previous 3 months that may affect the assessment or intervention. * Severe cognitive impairment. * Unwillingness to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation (AF)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dokuz Eylul University Hospital

    Izmir, Balçova, 35330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.